Related Experiment Video
Updated: Dec 28, 2025
10:37
Transcranial Direct Current Stimulation tDCS for Memory Enhancement
Published on: September 18, 2021
15.3K
Delaying memory decline: different options and emerging solutions.
Felicitas Schneider1, Alan Horowitz1, Klaus-Peter Lesch2,3,4
1Department of Bioinformatics, Biocenter, University of Würzburg, 97074, Würzburg, Germany.
Translational Psychiatry
|February 19, 2020
Summary
Memory decline affects aging populations, but various technologies show promise for enhancement. Future approaches like memory prosthetics and light therapy offer hope for treating memory loss.
Area of Science:
- Neuroscience
- Gerontology
- Biotechnology
Background:
- Memory decline is a significant issue in aging Western populations.
- Existing memory enhancement technologies offer potential therapeutic benefits.
Purpose of the Study:
- To review current and future memory enhancement technologies.
- To assess the efficacy of various approaches for memory improvement.
Main Methods:
- Review of scientific literature on memory enhancement strategies.
- Analysis of studies involving stem cell transplantation, vaccination, pharmaceuticals, dietary interventions, behavioral approaches, and emerging technologies.
Main Results:
- Stem cell transplantation and Alzheimer's disease (AD) vaccination show promise in animal models.
- Pharmaceuticals, Omega-3 fatty acids, and behavioral methods like sports and memory techniques demonstrate effectiveness.
- Augmented reality (AR), memory prosthetics, and light therapy are emerging as future possibilities.
Conclusions:
- Memory enhancement technologies offer significant promise for individuals with and without cognitive impairment.
- Further clinical investigation is required for the widespread application of these methods.
- Behavioral interventions and lifestyle changes can support memory function.
Related Concept Videos
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
456
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
456
01:30Cognitive Development During Adulthood
701
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
701
01:22Alzheimer's Disease: Treatment
699
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
699
01:26Alzheimer's Disease: Overview
1.5K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
01:03Long-term Depression
3.0K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
3.0K
01:05Long-term Depression
32.9K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
32.9K